Pharmaceutical Costs

In its May 30, 2017 decision Impression Products, Inc. v Lexmark International Inc., the Supreme Court ruled that patent law cannot be used to prevent the resale of products back into the United States. The Court case specifically concerned printer toner cartridges, but it is an important ruling in the context of the domestic policy […]

Read More
  • Drug Pricing: In the News

    As States Wage Battles on High Drug Prices, Drugmakers Fight Back May 18, 2017 Lembo targets ‘skyrocketing’ drug prices January 24, 2017 How can states tackle rising medication prices? January 11, 2017 Interfaith investor coalition pushes shareholder resolutions on drug prices, October 24, 2016 Politico Pulse mentioned the findings of the Pharmacy Costs Work Group, October 24, 2016 […]

    Read More
    June 6, 2017 | Filed under: Drug Pricing, Medicaid, Pharmaceutical Costs

  • Publications

    State Wholesale Importation Program Explained

    Because the federal government has not been able to agree on an approach to constrain prescription drug prices, states need to address the problem. Study after study show how U.S. consumers pay the highest prices in the world for life-saving and life-enhancing drug treatments. The prices we pay may fund the research and development that […]

    Read More
  • State Health Policy Blog

    Managing High Drug Prices through Importation: We Can Get to “YES”

    There is growing public pressure to find an effective way to address the rising prices of prescription drugs. Multiple drug price bills await action in Congress and more than 80 bills have been introduced in state legislatures in 2017. Among the variety of approaches aimed at managing drug prices, importation from other countries is an […]

    Read More
  • State Health Policy Blog

    Update: What’s New in State Drug Pricing Legislation?

    With 80 bills introduced in 2017, there is a high level of interest in pharmaceutical pricing among state legislators. However, despite legislative sessions wrapping up, very few laws have been enacted. To date, bills have passed in Maryland, Montana, New Mexico, New York, and Utah. In 2016, Vermont led the way with a price transparency […]

    Read More
  • Pharmacy Costs Work Group – Model Legislation

    Pharmacy Costs Work Group – Model Legislation

    NASHP, with guidance from our Pharmacy Costs Work Group, has developed model legislation for states that wish to pursue the policy options outlined in our paper States and the Rising Costs of Pharmaceuticals: A Call to Action. States interested in this model legislation will have access to a legislator’s guide and additional background materials as […]

    Read More
    March 12, 2017 | Filed under: Drug Pricing, Pharmaceutical Costs

  • Pharmacy Costs Workgroup: Model Drug Price Transparency Legislation

    Pharmaceutical prices are rising, driving up premiums and out of pocket costs. State budgets – that by law, have to be balanced– are reeling from high and unpredictable pharmaceutical price increases for Corrections, state employees and retirees, K-12 and public  university employees, and, of course,  Medicaid. To address rapidly rising prescription drug prices, purchasers and policy […]

    Read More
  • State Health Policy Blog

    NASHP Releases Model Rx Transparency Legislation

    Pharmaceutical prices are rising, driving up premiums and out-of-pocket costs. Today, 21 percent of spending in employer-sponsored plans goes to retail prescription drugs.[i] State budgets – which by law must be balanced- are reeling from high and unpredictable pharmaceutical increases for corrections, state employees and retirees, K-12 and public university employees, and, of course, Medicaid. […]

    Read More
  • Webinars

    Webinar Addresses Rising Cost of Pharmaceuticals

    In this webinar, members of the National Academy for State Health Policy’s Pharmacy Costs Workgroup review 11 specific proposals for how states may curb the rising cost of pharmaceuticals. NASHP’s work group looks broadly at states as purchasers, regulators, policymakers, and investors to develop the next generation of state–based reforms to address the rapid growth […]

    Read More
  • Publications
    States and the Rising Cost of Pharmaceuticals: A Call to Action

    States and the Rising Cost of Pharmaceuticals: A Call to Action

    As part of the 29th Annual State Health Policy Conference, held 17-19 in Pittsburgh, PA, NASHP released findings from our Pharmacy Costs Work Group aimed at addressing the increasingly rising costs of pharmaceuticals.  The solutions offered in the newly released findings serve as a toolbox for states. While they recognize the value of the pharmaceutical industry, state policymakers […]

    Read More